T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Life Time Group Holdings
LTH
$9.9B
| $165K | ﹤0.01% |
10,903
+810
| +8% | +$11.6K |
|
|
XRN
2602
Chiron Real Estate Inc
XRN
$484M
| $164K | ﹤0.01% |
2,939
+182
| +7% | +$8.82K |
|
2603
Rimini Street
RMNI
$470M
| $163K | ﹤0.01% |
49,697
-12,373
| -20% | -$34K |
|
2604
The Joint Corp
JYNT
$119M
| $160K | ﹤0.01% |
16,627
| – | – |
|
2605
Phathom Pharmaceuticals
PHAT
$743M
| $159K | ﹤0.01% |
17,401
+4,007
| +30% | +$34.5K |
|
2606
Aldeyra Therapeutics
ALDX
$86.9M
| $158K | ﹤0.01% |
44,827
+4,935
| +12% | +$15.2K |
|
2607
Ranpak Holdings
PACK
$479M
| $158K | ﹤0.01% |
27,077
+496
| +2% | +$2.1K |
|
2608
The RealReal
REAL
$1.33B
| $158K | ﹤0.01% |
78,200
+1,500
| +2% | +$2.92K |
|
2609
ClearPoint Neuro
CLPT
$470M
| $157K | ﹤0.01% |
23,054
+688
| +3% | +$3.89K |
|
2610
Stoke Therapeutics
STOK
$2.02B
| $157K | ﹤0.01% |
29,789
| – | – |
|
|
LGF.A
2611
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $156K | ﹤0.01% |
14,226
+811
| +6% | +$7.38K |
|
2612
Lexicon Pharmaceuticals
LXRX
$1.04B
| $155K | ﹤0.01% |
100,691
| – | – |
|
|
SELF
2613
Global Self Storage
SELF
$58.9M
| $155K | ﹤0.01% |
33,399
| – | – |
|
|
IVAC
2614
DELISTED
Intevac Inc
IVAC
| $155K | ﹤0.01% |
35,846
+631
| +2% | +$2.35K |
|
|
MPX
2615
DELISTED
Marine Products Corp
MPX
| $154K | ﹤0.01% |
13,490
| – | – |
|
|
MURA
2616
DELISTED
Mural Oncology
MURA
| $154K | ﹤0.01% |
+25,992
| New | +$105K |
|
2617
Pangaea Logistics
PANL
$496M
| $154K | ﹤0.01% |
18,646
+417
| +2% | +$2.81K |
|
2618
nLIGHT
LASR
$2.9B
| $153K | ﹤0.01% |
+11,268
| New | +$126K |
|
2619
Horizon Bancorp
HBNC
$1.05B
| $152K | ﹤0.01% |
+10,598
| New | +$120K |
|
2620
RPC Inc
RES
$1.39B
| $152K | ﹤0.01% |
20,743
+1,546
| +8% | +$12.1K |
|
2621
Smith & Wesson
SWBI
$643M
| $152K | ﹤0.01% |
11,159
+852
| +8% | +$11.7K |
|
2622
Altimmune
ALT
$560M
| $151K | ﹤0.01% |
13,417
+3,370
| +34% | +$14.1K |
|
2623
Rigel Pharmaceuticals
RIGL
$762M
| $151K | ﹤0.01% |
10,393
+368
| +4% | +$3.76K |
|
2624
SIGA Technologies
SIGA
$207M
| $151K | ﹤0.01% |
26,962
+620
| +2% | +$3.32K |
|
2625
Select Water Solutions
WTTR
$2.63B
| $151K | ﹤0.01% |
19,851
+1,802
| +10% | +$13.4K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.